Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate in the following investor conferences:
Stifel Healthcare Conference
- Dates: November 10–12, 2026
- Location: New York, United States
Fireside chat:
- Date: November 10, 2026
- Time: 2:00 p.m. ET / 8:00 p.m. CET
- To enter the live webcast, please click here
The link to access the live webcast of the presentation will be available on the Events page of the Investors section of Innate Pharma’s website. A replay of the presentation will be available following the event.
Jefferies Global Healthcare Conference
- Dates: November 16-19, 2026
- Location: London, United Kingdom
| Press release in English | 129.71 KB |
| Communiqué de presse en français | 126.9 KB |